These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 18521895)

  • 1. Self-crosslinked and reducible fusogenic peptides for intracellular delivery of siRNA.
    Mok H; Park TG
    Biopolymers; 2008 Oct; 89(10):881-8. PubMed ID: 18521895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracellular siRNA delivery system using polyelectrolyte complex micelles prepared from VEGF siRNA-PEG conjugate and cationic fusogenic peptide.
    Lee SH; Kim SH; Park TG
    Biochem Biophys Res Commun; 2007 Jun; 357(2):511-6. PubMed ID: 17434451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifunctional siRNA delivery system: polyelectrolyte complex micelles of six-arm PEG conjugate of siRNA and cell penetrating peptide with crosslinked fusogenic peptide.
    Choi SW; Lee SH; Mok H; Park TG
    Biotechnol Prog; 2010; 26(1):57-63. PubMed ID: 19918765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cationic solid lipid nanoparticles reconstituted from low density lipoprotein components for delivery of siRNA.
    Kim HR; Kim IK; Bae KH; Lee SH; Lee Y; Park TG
    Mol Pharm; 2008; 5(4):622-31. PubMed ID: 18461969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative evaluation of target-specific GFP gene silencing efficiencies for antisense ODN, synthetic siRNA, and siRNA plasmid complexed with PEI-PEG-FOL conjugate.
    Kim SH; Mok H; Jeong JH; Kim SW; Park TG
    Bioconjug Chem; 2006; 17(1):241-4. PubMed ID: 16417275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antisense oligodeoxynucleotide-conjugated hyaluronic acid/protamine nanocomplexes for intracellular gene inhibition.
    Mok H; Park JW; Park TG
    Bioconjug Chem; 2007; 18(5):1483-9. PubMed ID: 17602578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PEG conjugated VEGF siRNA for anti-angiogenic gene therapy.
    Kim SH; Jeong JH; Lee SH; Kim SW; Park TG
    J Control Release; 2006 Nov; 116(2):123-9. PubMed ID: 16831481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation and delivery of siRNA by oleic acid and stearic acid modified polyethylenimine.
    Alshamsan A; Haddadi A; Incani V; Samuel J; Lavasanifar A; Uludağ H
    Mol Pharm; 2009; 6(1):121-33. PubMed ID: 19053537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conjugation of siRNA with comb-type PEG enhances serum stability and gene silencing efficiency.
    Gunasekaran K; Nguyen TH; Maynard HD; Davis TP; Bulmus V
    Macromol Rapid Commun; 2011 Apr; 32(8):654-9. PubMed ID: 21480423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyethylenimine PEI F25-LMW allows the long-term storage of frozen complexes as fully active reagents in siRNA-mediated gene targeting and DNA delivery.
    Höbel S; Prinz R; Malek A; Urban-Klein B; Sitterberg J; Bakowsky U; Czubayko F; Aigner A
    Eur J Pharm Biopharm; 2008 Sep; 70(1):29-41. PubMed ID: 18499413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multifunctional and reversibly polymerizable carrier for efficient siRNA delivery.
    Wang XL; Nguyen T; Gillespie D; Jensen R; Lu ZR
    Biomaterials; 2008 Jan; 29(1):15-22. PubMed ID: 17923154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Target-specific gene silencing by siRNA plasmid DNA complexed with folate-modified poly(ethylenimine).
    Hwa Kim S; Hoon Jeong J; Chul Cho K; Wan Kim S; Gwan Park T
    J Control Release; 2005 May; 104(1):223-32. PubMed ID: 15866348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mesoporous silica nanoparticle--PEI--fusogenic peptide system for siRNA delivery in cancer therapy.
    Li X; Chen Y; Wang M; Ma Y; Xia W; Gu H
    Biomaterials; 2013 Jan; 34(4):1391-401. PubMed ID: 23164421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disulfide crosslinked stearoyl carrier peptides containing arginine and histidine enhance siRNA uptake and gene silencing.
    Tanaka K; Kanazawa T; Ogawa T; Takashima Y; Fukuda T; Okada H
    Int J Pharm; 2010 Oct; 398(1-2):219-24. PubMed ID: 20674725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular small interfering RNA delivery using genetically engineered double-stranded RNA binding protein domain.
    Kim J; Lee SH; Choe J; Park TG
    J Gene Med; 2009 Sep; 11(9):804-12. PubMed ID: 19569061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient delivery of Bcl-2-targeted siRNA using cationic polymer nanoparticles: downregulating mRNA expression level and sensitizing cancer cells to anticancer drug.
    Beh CW; Seow WY; Wang Y; Zhang Y; Ong ZY; Ee PL; Yang YY
    Biomacromolecules; 2009 Jan; 10(1):41-8. PubMed ID: 19072631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folate-linked lipid-based nanoparticles for synthetic siRNA delivery in KB tumor xenografts.
    Yoshizawa T; Hattori Y; Hakoshima M; Koga K; Maitani Y
    Eur J Pharm Biopharm; 2008 Nov; 70(3):718-25. PubMed ID: 18647651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Di- and triblock siRNA-PEG copolymers: PEG density effect of polyelectrolyte complexes on cellular uptake and gene silencing efficiency.
    Lee SH; Mok H; Park TG
    Macromol Biosci; 2011 Mar; 11(3):410-8. PubMed ID: 21080384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reducible poly(amido ethylenimine) directed to enhance RNA interference.
    Hoon Jeong J; Christensen LV; Yockman JW; Zhong Z; Engbersen JF; Jong Kim W; Feijen J; Wan Kim S
    Biomaterials; 2007 Apr; 28(10):1912-7. PubMed ID: 17218006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracellular trafficking and unpacking of siRNA/quantum dot-PEI complexes modified with and without cell penetrating peptide: confocal and flow cytometric FRET analysis.
    Lee H; Kim IK; Park TG
    Bioconjug Chem; 2010 Feb; 21(2):289-95. PubMed ID: 20078095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.